{
  "id": 12588932,
  "title": "Viatris’s pipeline strategy: Moving beyond generics to find new growth",
  "url": "https://urgent.news/2026/10/06/viatriss-pipeline-strategy-moving-beyond-generics-to-find-new-growth",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T13:00:00.000Z",
  "source": {
    "name": "Labiotech",
    "slug": "labiotech",
    "url": "https://www.labiotech.eu/top-pharma-strategy/viatris-pipeline-strategy/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Delve into the strategy of Viatris, a company that built its reputation around generics and is steadily moving beyond to find new growth. The post Viatris’s pipeline strategy: Moving beyond generics to find new growth appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "IOL",
        "title": "Beyond the Pink Wave: Moving from Awareness to Early Detection and Support",
        "url": "https://urgent.news/2026/10/05/beyond-the-pink-wave-moving-from-awareness-to-early-detection-and",
        "published": "2026-10-05T10:10:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}